Benzinga | May 4, 2021 08:17AM EDT

Elanco Animal Health Introduces Credelio CAT (lotilaner), First Oral Flea And Tick Product For Cats

Veterinarians in the U.S. now have a new, innovative option for flea and tick control as Elanco Animal Health Incorporated (NYSE:ELAN) introduces Credelio Cat, the first oral flea and tick product for cats.

Credelio Cat starts killing fleas on cats within 6 hours. The small, chewable product maintains fast-acting, sustained flea efficacy throughout the month in cats 8 weeks and older. Credelio Cat also protects against black-legged ticks throughout the month in cats 6 months and older. Black-legged ticks are the most prevalent tick species in cats in the U.S.1

"Even indoor cats are at risk of fleas and ticks," said Dr. Tony Rumschlag, Senior Director, Technical Consulting. "It's great to have a first-of-its-kind flea and tick option for cat owners who prefer oral administration or want to try something besides a topical. Credelio Cat, which uses the active ingredient, lotilaner, has been shown to be safe and effective when used according to label directions for killing fleas in cats as young as 8 weeks weighing 2 or more pounds, so veterinarians can feel good about prescribing it to their patients."

While the administration of orals has been challenging in the past, Credelio Cat was designed specifically for cats, ensuring its vanilla and yeast scent and flavor would be appealing.2 The product was successfully administered by 99.5% of cat owners in a U.S. field study.3

Approved by the U.S. Food and Drug Administration (FDA), Credelio Cat joins Elanco's growing pet health portfolio, which includes solutions in the areas of parasiticides, pain management, vaccines, internal medicine, oncology and dermatology.

For more information about Credelio Cat and Elanco's cat health portfolio, please visit: https://www.elanco.us/products-services/cats/credelio-cat